Stock D4S DAIICHI SANKYO CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Daiichi Sankyo Co., Ltd. Deutsche Boerse AG

Equities

D4S

JP3475350009

Market Closed - Deutsche Boerse AG
Other stock markets
 02:01:25 2024-07-12 am EDT 		After market 04:01:52 pm
34.94 EUR +0.72% Intraday chart for Daiichi Sankyo Co., Ltd. 34.84 -0.29%
Jul. 10 Daiichi Sankyo Opens New Affiliate for Oncology in Greece CI
Jul. 02 Financials lift Japanese shares on rate-hike speculation RE

Evolution of the average Target Price on Daiichi Sankyo Co., Ltd.

Price target over the last 5 years

History of analyst recommendation changes

41.4bjibQTnm3wcXqjGeJEVxnc0-YyjVkC8cfTk8YRiR00.jZXbWGnRohVPZ9CoGdtMsy1WwN6RAnLGIba8l9EAAHrM8IsDUYbIS38SmA~49793d814e63bb2dd0f4cdabd4e9483f

Analyst Recommendations on Daiichi Sankyo Co., Ltd.

Jefferies Adjusts Daiichi Sankyo’s Price Target to 6,600 Yen From 5,600 Yen, Keeps at Buy MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 5,600 Yen From 4,800 Yen, Keeps at Buy MT
Jefferies Upgrades Daiichi Sankyo to Buy From Hold, Adjusts Price Target to 4,800 Yen From 4,300 Yen MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,300 Yen From 3,900 Yen, Keeps at Hold MT
Jefferies Downgrades Daiichi Sankyo to Hold From Buy, Adjusts Price Target to 1,900 Yen From 2,000 Yen MT
Jefferies Adjusts Daiichi Sankyo’s Price Target to 4,800 Yen From 5,300 Yen, Keeps at Buy MT
Jefferies Adjusts Daiichi Sankyo's Price Target to 5,300 Yen From 4,300 Yen, Keeps at Buy MT
MARKETSCREENER'S WORLD PRESS REVIEW : June 6, 2022 Our Logo
Japanese shares jump on Fed's growth view, rate pledge RE
Daiichi Sankyo Company, Limited Announces New 12-Month Analysis Data from ETNA-AF Non-Interventional Study Show Low Bleeding and ICH Rates in Frail and Ageing AF Patients on LIXIANA CI
Japanese stocks slip as economy shrinks at record rate on pandemic hit RE
Astrazeneca and Daiichi Sankyo Company, Limited Announces ENHERTU (Fam-Trastuzumab Deruxtecan-Nxki) Significantly Improved Tumor Response Rate and Overall Survival in HER2-Positive Metastatic Gastric Cancer in Phase II Destiny-Gastric01 Trial CI
Royal Philips : AstraZeneca raises sales forecast after second quarter cancer drug, China boost RE
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
15
Last Close Price
5,987 JPY
Average target price
6,228 JPY
Spread / Average Target
+4.03%
High Price Target
6,800 JPY
Spread / Highest target
+13.58%
Low Price Target
4,900 JPY
Spread / Lowest Target
-18.16%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Daiichi Sankyo Co., Ltd.

Jefferies & Co.

Ratings for Daiichi Sankyo Co., Ltd.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 4568 Stock
  4. D4S Stock
  5. Consensus Daiichi Sankyo Co., Ltd.